期刊
GENERAL HOSPITAL PSYCHIATRY
卷 47, 期 -, 页码 36-42出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.genhosppsych.2017.04.006
关键词
Anxiety; Chronic pain; Prescription opioids; Opioid misuse
类别
资金
- Investigator Initiated Grant from Reckitt Benckiser Pharmaceuticals
Objective: In the past two decades, chronic pain has been increasingly treated with prescription opioids, particularly in developed countries. This has drawn public concern of possible risks associated with the potential misuse of prescriptions opioids. Previous research has indicated that this may be particularly true among individuals suffering from co-occurring psychiatric disorders. The present study sought to explore rates of misuse among chronic pain patients prescribed opioids, comparing individuals with and without anxiety. Methods: Chronic pain patients receiving prescription opioids (N = 554) were screened for anxiety using the Generalized Anxiety Disorder (GAD-7) scale and for opioid misuse using the Current Opioid Misuse Measure (COMM). Results: Among patients who screened positive for anxiety (GAD-7 >= 10), 50% also screened positive for opioid misuse, compared to 10% among those without anxiety. After controlling for possible confounding sociodemographic and clinical variables, patients with anxiety were significantly more prone to screen positive for opioid misuse (Adjusted Odds Ratio (AOR) = 2.18; 95% Confidence Interval (CI) = 1.37-4.17) compared to those without anxiety. This was maintained when conducting separate comparisons for severe, but not mild or moderate, level of anxiety. Conclusions: These findings highlight the importance of detecting and addressing co-occurring anxiety when treating patients with chronic pain who receive prescription opioids.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据